Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Eligibility and Supervised Use Saxenda is particularly recommended for individuals with a Body Mass Index (BMI) exceeding 30 kg/m, or for those with a BMI over 27 kg/m accompanied by chronic conditions such as hypertension, type 2 diabetes, or hyperlipidemia
One of the clearest findings from long-term research is that weight regain is common after GLP-1 treatment ends
Business Type Exporter, Manufacturer, Service Provider, Distributor, Supplier, Trading Company Employee Count 60 Establishment 2006 Working Days To GST NO 24AAFCE1958B1Z0 Payment Mode Online Payments (NEFT/RTGS/IMPS) Related Products Explore Related Categories More Products From This Seller Seller Details GST - 24AAFCE1958B1Z0 Trusted Seller Rajkot, Gujarat CEO Mr Manish Rachh Members since 9 Years Address Plot No.32 & 33, GIDC, Kuvadava, Rajkot, Gujarat, 360023, India third party manufacturing in Rajkot Report incorrect details
however, several challenges still remain, especially the higher cost of a combined therapy and the worldwide underuse of either GLP-1RAs or SGLT2is in clinical practice, even in patients at high cardiorenal risk
US$ 22.15
US$ 28.30
US$ 20.25
US$ 23.47
US$ 20.04
US$ 20.14
